Derazantinib (ARQ 087) in Advanced or Inoperable FGFR2 Gene Fusion-Positive Intrahepatic Cholangiocarcinoma

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0334-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Intrahepatic Cholangiocarcinoma

2020English

Intrahepatic Cholangiocarcinoma

2018English

Intrahepatic Sarcomatoid Cholangiocarcinoma

Journal of Oncology
Oncology
2010English

HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma

Hepatology
MedicineHepatology
2018English

Intrahepatic Cholangiocarcinoma: MR Appearance.

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
1992English

Molecular Diagnosis of Intrahepatic Cholangiocarcinoma

Journal of Hepato-Biliary-Pancreatic Sciences
SurgeryHepatology
2014English

A Case of Intrahepatic Cholangiocarcinoma With Intrahepatic Stones.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1992English

Intrahepatic Cholangiocarcinoma: Expert Consensus Statement

HPB
HepatologyGastroenterology
2015English

Intrahepatic Biliary Paracoccidioidomycosis Mimicking Cholangiocarcinoma

Journal of Gastrointestinal and Liver Diseases
MedicineGastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy